Becton Dickinson & Co.: Device Recall
Recall #Z-2023-2025 · 05/20/2025
Class II: Risk
Recall Details
- Recall Number
- Z-2023-2025
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Becton Dickinson & Co.
- Status
- Ongoing
- Date Initiated
- 05/20/2025
- Location
- Sparks, MD, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,256 eaches
Reason for Recall
BD has received additional complaints of intermittent false resistance results for PZA during susceptibility testing of Mycobacterium tuberculosis isolates.
Product Description
BD BACTEC" MGIT" 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (PZA).
Distribution Pattern
Worldwide distribution - US Nationwide and the countries of AR, AU, BD, BE, BN, BR, CA, CN, CR, DO, GT, HK, HT, ID, IN, JP, KH, KR, MO, MX, MY, NP, NZ, PE, PH, PK, SG, SV, TH, TW, VN.
Other Recalls by Becton Dickinson & Co.
- Class II: Risk 10/23/2025
- Class II: Risk 09/23/2025
- Class II: Risk 09/23/2025
- Class II: Risk 09/23/2025
- Class II: Risk 09/23/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.